Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2.

A Lindemann; P Brossart; K Höffken; M Flasshove; D Voliotis; V Diehl; P Kulmburg; H Wagner; R Mertelsmann

doi:10.1097/00002371-199404000-00009

Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2.

Identifier:nobleid.org/w1/20260515/0B240CFD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0B240CFD.svg?ark=w1%2F20260515%2F0B240CFD)](https://nobleid.org/work/w1/20260515/0B240CFD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2.

Identifier:nobleid.org/w1/20260515/0B240CFD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0B240CFD.svg?ark=w1%2F20260515%2F0B240CFD)](https://nobleid.org/work/w1/20260515/0B240CFD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work